These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

275 related items for PubMed ID: 4491709

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Clinical effects of rifampicin for pulmonary tuberculosis patients. 1. Comparison of rifampicin-ethambutol-isoniazid with streptomycin-paraminosalcylic acid-isoniazid in the original treatment of pulmonary tuberculosis patients].
    Kekkaku; 1971 Oct; 46(10):393-9. PubMed ID: 5147895
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Clinical effect of rifampicin-ethambutol isoniazid on untreated pulmonary tuberculosis.
    Konno K, Oizumi K, Yamada S, Ogata K, Sato M.
    Sci Rep Res Inst Tohoku Univ Med; 1972 Sep; 19(2):68-72. PubMed ID: 4649624
    [No Abstract] [Full Text] [Related]

  • 5. [Rifampicin in the treatment of active pulmonary tuberculosis. Controlled trial of isoniazid-rifampicin-thiocarlide versus isoniazid-streptomycin-thiocarlide in untreated tuberculosis. Treatment of relapses with the combination rifampicin-ethambutol-thiocarlide].
    Chioléro R.
    Schweiz Med Wochenschr; 1974 Mar 09; 104(10):356-64. PubMed ID: 4206521
    [No Abstract] [Full Text] [Related]

  • 6. Modern management of tuberculosis.
    Promisloff RA, Johnston RF.
    Compr Ther; 1979 Oct 09; 5(10):25-37. PubMed ID: 498742
    [No Abstract] [Full Text] [Related]

  • 7. Drugs for tuberculosis.
    Med Lett Drugs Ther; 1995 Aug 04; 37(954):67-70. PubMed ID: 7616907
    [No Abstract] [Full Text] [Related]

  • 8. [Initial resistance to streptomycin, isoniazid, rifampicin and ethambutol in bacillus-laden tuberculosis patients at the National Center of Pneumo-physiology at Cotonou (Benin)].
    Anagonou SY, Gninafon M, Josse R, Kinde-Gazard D, Tawo L, Foundohou J.
    Bull Soc Pathol Exot; 1993 Aug 04; 86(2):144-7. PubMed ID: 8353477
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Initial treatment of tuberculosis with rifampicin.
    O'Connell J, Campbell AH, Cowen K, Verins A.
    Med J Aust; 1973 Nov 10; 2(19):881-5. PubMed ID: 4765873
    [No Abstract] [Full Text] [Related]

  • 11. A triple regimen of streptomycin, isoniazid and ethambutol or rifampicin, isoniazid and ethambutol in untreated cases of pulmonary tuberculosis. 3.
    Oka S, Sasaki M, Kobayashi T, Matsuda T.
    Sci Rep Res Inst Tohoku Univ Med; 1972 Sep 10; 19(2):84-8. PubMed ID: 4649627
    [No Abstract] [Full Text] [Related]

  • 12. [Rifampicin in the treatment of lung and kidney tuberculosis].
    Kraan JK, Mulder RJ, Mulder-De Jong MT, van Dijk B.
    Ned Tijdschr Geneeskd; 1972 Jan 01; 116(1):9-15. PubMed ID: 4555064
    [No Abstract] [Full Text] [Related]

  • 13. Management of tuberculosis in elderly persons.
    Nagami P, Yoshikawa TT.
    Compr Ther; 1984 Jul 01; 10(7):57-62. PubMed ID: 6540155
    [No Abstract] [Full Text] [Related]

  • 14. [Maximum therapeutic efficiency of a guternary antitubercular preparation. (Streptomycin-ethambutol-rifampicin-isoniazid)].
    Almansa de Cara S.
    Rev Clin Esp; 1972 May 31; 125(4):353-6. PubMed ID: 5080180
    [No Abstract] [Full Text] [Related]

  • 15. [Proceedings: Preliminary results of a 2-phase therapy with rifampicin, ethambutol and a third drug in chronic polyresistant tuberculoses].
    Neumeyer D, Anschel R, Eule H, Fichtner K, Ganguin HG, Pickroth G.
    Z Erkr Atmungsorgane Folia Bronchol; 1973 May 31; 138(1):135-8. PubMed ID: 4491710
    [No Abstract] [Full Text] [Related]

  • 16. [Results of initial treatment of pulmonary tuberculosis using ethambutol, isonicotinic acid hydrazide and rifampicin].
    Kesztele V, Niederkofler J.
    Wien Med Wochenschr; 1970 Jun 20; 120(25):473-5. PubMed ID: 5518004
    [No Abstract] [Full Text] [Related]

  • 17. Short-course treatment regimens for patients with tuberculosis.
    Dutt AK, Stead WW.
    Arch Intern Med; 1980 Jun 20; 140(6):827-9. PubMed ID: 6770770
    [No Abstract] [Full Text] [Related]

  • 18. [Proceedings: Significance and limits of controlled clinical research (in pulmonary tuberculosis)].
    Bignall JR.
    Z Erkr Atmungsorgane Folia Bronchol; 1973 Jun 20; 138(1):103-6. PubMed ID: 4588016
    [No Abstract] [Full Text] [Related]

  • 19. Quality assurance programme for drug susceptibility testing of Mycobacterium tuberculosis in the WHO/IUATLD Supranational Laboratory Network: first round of proficiency testing.
    Laszlo A, Rahman M, Raviglione M, Bustreo F.
    Int J Tuberc Lung Dis; 1997 Jun 20; 1(3):231-8. PubMed ID: 9432369
    [Abstract] [Full Text] [Related]

  • 20. [Rifampicin in the treatment of newly detected adolescent pulmonary tuberculosis patients].
    Ganiev KG, Esanbaev DE, Kirina SB.
    Probl Tuberk; 1983 May 20; (5):42-6. PubMed ID: 6866983
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.